Compare FRAF & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FRAF | OSUR |
|---|---|---|
| Founded | 1906 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 206.3M | 177.2M |
| IPO Year | N/A | 1986 |
| Metric | FRAF | OSUR |
|---|---|---|
| Price | $52.91 | $2.46 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 37.8K | ★ 797.4K |
| Earning Date | 01-27-2026 | 11-05-2025 |
| Dividend Yield | ★ 2.47% | N/A |
| EPS Growth | ★ 9.43 | N/A |
| EPS | ★ 3.50 | N/A |
| Revenue | $77,783,000.00 | ★ $125,703,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.70 |
| P/E Ratio | $15.23 | ★ N/A |
| Revenue Growth | ★ 8.75 | N/A |
| 52 Week Low | $28.01 | $2.08 |
| 52 Week High | $54.72 | $4.22 |
| Indicator | FRAF | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 67.49 | 47.94 |
| Support Level | $52.04 | $2.44 |
| Resistance Level | $54.72 | $2.60 |
| Average True Range (ATR) | 1.19 | 0.12 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 77.83 | 73.33 |
Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.